1. Home
  2. KFS vs EOLS Comparison

KFS vs EOLS Comparison

Compare KFS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kingsway Financial Services Inc. (DE)

KFS

Kingsway Financial Services Inc. (DE)

HOLD

Current Price

$12.23

Market Cap

352.8M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.30

Market Cap

304.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFS
EOLS
Founded
1989
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
352.8M
304.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
KFS
EOLS
Price
$12.23
$4.30
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.40
AVG Volume (30 Days)
74.5K
1.1M
Earning Date
03-16-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$128,567,000.00
$285,823,000.00
Revenue This Year
N/A
$13.70
Revenue Next Year
N/A
$13.40
P/E Ratio
N/A
N/A
Revenue Growth
18.31
15.10
52 Week Low
$7.06
$4.09
52 Week High
$16.80
$17.12

Technical Indicators

Market Signals
Indicator
KFS
EOLS
Relative Strength Index (RSI) 34.61 32.43
Support Level $13.18 $4.09
Resistance Level $13.27 $4.61
Average True Range (ATR) 0.42 0.27
MACD -0.11 0.02
Stochastic Oscillator 1.28 23.22

Price Performance

Historical Comparison
KFS
EOLS

About KFS Kingsway Financial Services Inc. (DE)

Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: